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BIOLOGICAL ENGINEERING: ADVANCES AND METHODS 
Joel Schwartz 
ABSTRACT 
The last few decades have seen a tremendous growth in the field of bioengineering. As 
the need for further treatment and innovation for tissue repair, partial to full organ replication, 
and gene therapy continues to increase, the field of bioengineering will be tasked with curing and 
preventing disease and traumatic injuries. The two primary fields currently being focused on in 
the lab are the way cells interact and communicate to build tissues, and the nature and materials 
utilized in scaffolding to allow differentiation and migration when cells are seeded. Within those 
two fields are subsets of different methods, materials that vary greatly. Some stem cells offer 
certain benefits, yet lack viability due to a host of obstacles, such as ethical questions about their 
procurement, to their technical obstacles, such as materials utilized for best profusion in a 
scaffold. It appears that proper and adequate funding for research into finding solutions will be 
pivotal in having the next medical breakthrough in science. It may very well be referred as one of 
the greatest advancements in modern history and forever change the face of science should this 
technology become successful and accessible. Indeed, recent successes in patients would be a 
strong indicator that this technology and innovation is not too distant in the future. 
INTRODUCTION 
Currently, in the US alone, there are over 100,000 candidates awaiting organs on the 
national organ waiting list. On average, a person on that waiting list dies every 90 minutes 
(UNOS 2012). In addition, as the amount of recipients is increasing, the amount of donors is 
decreasing. This is due to factors such as ethical debates and customs regarding organ donation, 
and the fact that organs may only be harvested coincident with brainstem death, which 
necessitates hospitals utilize additional resources to keep patients on life support (Briggs et 
al.1997). While technology and advanced methods have fine-tuned the science of organ 
transplants, it does not address the need for more organs. In addition, tissues such as cartilage, 
muscle, and even neural tissue for regeneration in vivo can have a tremendous impact on overall 
life quality in a patient. In response to this need, the last 30 years have been a whirlwind of 
activity for researchers to try and replicate and build new tissues and organs, thus creating the 
field of biological engineering. An early example of tissue engineering was developed by Dr. J. 
Burke of Massachusetts General Hospital. He created a synthetic neodermal skin utilizing 
chrondroitin 6-sulface in tandem with collagen, to cover burn patients while their skin was in the 
process of regenerating.    
Bioengineering is multifaceted and has many working and intrinsic parts. It requires an in 
depth and interdisciplinary understanding of the biological cell such as its embryonic origin, 
cycle, replication, metabolism, energy requirements and proliferation stages, as well as a keen 
understanding of structural engineering, materials unique in biological adsorption or absorption, 
chemical compounds and nanotechnology to pair them together in a hybrid organ. 
At the fundamental level, it begins with the cell, specifically using an embryonic stem 
cell or mature adult progenitor cell (MAPC) to direct and grow. However, having cells 
proliferate is not enough, as a clump of differentiated cells is all that would be present, hence the 
need for scaffolding as well. Scaffolding is tasked with providing a three dimensional structure 
for the cells to grow on and to deliver growth factors to nurture the cells. Study and research 
analyzing embryonic and adult stem cells and its methods of use, as well as the requirements 
scaffolding need to become viable, and assess and evaluate which of the many scaffolding 
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materials/methods currently being tested, hold the most promise for full organ replication in the 
near future.  
1. STEM CELL ROLE IN REGENERATIVE ENGINEERING 
Stem cells were discovered to have the ability to replicate and divide into any type of cell 
in the body (plasticity). This opened up the possibility for regenerating diseased tissue or failing 
organs by reseeding those areas with stem cells to differentiate and proliferate to become the new 
cells in those areas. When combined with the proper method of feeder lines and guided cell 
growth, the development of the cell can be accomplished. There are several different types of 
stem cells, each with its own unique set of benefits and characteristics. Some exhibit obstacles as 
well, and are in the process of being studied.  
HUMAN EMBRYONIC STEM CELLS  
Stem cells isolated from the embryo are achieved in chronological proximity to egg 
fertilization. These cells are derived from the inner mass of the blastocyst cell after four to six 
days of gestation, at which point they number approximately one hundred fifty cells, comprised 
of none differentiated and totipotent cells. They will continue on to form the more than two 
hundred tissue types in the human body. Derivation is executed through several means. The 
primary and most successful method utilized, is by removing the outer trophectoderm via 
immunosurgery thus exposing the inner mass cell (ICM) for disaggregation and plating on a 
feeder cell layer for further culture. Cultivation of stem cells is maintained by providing the 
proper nutrients such as proteins and growth factors, which can be efficiently done if cells are in 
a suspension medium, specific to the cell's needs. At day six, these cells will enter the blastocyst 
stage and have differentiated into trophectoderm and an inner cell mass that includes the 
progenitors of all the cells in the body. Thus the embryonic stem cell has tremendous potential 
for differentiation into any type of cell needed, and is unique in its capacity to propagate without 
losing pluripotency, thus may readily differentiate into various cell types of the 
three embryonic germ layers. An additional advantage of human embryonic stem cells is the 
relative ease with which they can be genetically engineered by a broad range of techniques such 
as transfection, electroporation, and viral infection (Power and Rasko 2011). Human embryonic 
stem cells have the additional advantage of rapid mitosis as well, and can divide at an 
exponential rate.  However, unless the stem cell is banked from the recipients own stem cells, 
rejection is still possible and quite likely. Additionally, there are many ethical debates about 
whether utilizing embryonic stem cells. Primarily, the concern seems to be that according to one 
school of thought, life begins at inception, so extracting cells from a fertilized egg is akin to 
destroying life (Briggs et al. 1997). Additionally, due to its extreme proliferative nature, they 
often can become cancerous and form teratomas. Indeed, there have been documented cases of 
tumors containing fully formed teeth or retinas. 
On the other hand, there are many advantages to utilizing embryonic stem cells. 
Primarily, these cells exhibit the ability to unlimited or prolonged self-renewal and the potential 
to produce all the differentiated cell types necessary for any specific tissue. Their embryonic 
state allows for exponential growth that can propagate, assuring robust growth. Due to their 
ability to differentiate into any type of cell, all tissue types can be generated. Additionally, the 
extreme plasticity of the cell makes it an ideal candidate for programming the cell DNA to 
express the specific differentiation desired. However, although human embryonic stem cells are 
not yet differentiated, they are already coded in their DNA for the proteins and markers they will 
exhibit. This can lead to host rejection should an immune response be initiated. Creating a cell 
bank with all the different types of HLA (human leukocyte antigen) to act as a reserve for 
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matching the specific needs of recipients would certainly address the issue of host rejection and 
would drastically decrease the amount of time a recipient would need to wait for the quorum of 
cells needed for transplant (Cabrera et al. 2006).  
MATURE ADULT PROGENITOR CELLS 
Mature progenitor cells have proven most successful in the clinical aspect.  This is due to 
its already partially differentiated state, which makes the manipulation and direction of 
differentiation more viable.  Mature adult progenitor cells do not illicit host rejection, when it is 
the recipient’s very own cell.  However, it does have certain limitations.  The main obstacle with 
progenitor cells, is that they are already differentiated, thus making them only viable for their 
specific cell of origin. Additionally, sometimes the area where the progenitor cells may be from, 
are in a necrotic state and viable cells for extraction is no longer possible. When that is the case, 
receiving progenitor cells from a donor will result in the same problems of host rejection due to 
different phenotype. (Shokier et al. 2010). Additionally, the use of stem cells eliminates the need 
for lifelong immunosuppressant drugs as the stem cells utilized for regeneration is the recipient’s 
own cells. Additionally it has been found that when these cells are encapsulated with Fibrin, they 
secrete more collagen. (Lin et al. 2010) 
Mature adult progenitor cells are primarily selected from bone marrow derived 
mesenchymal stem cells (BMSCS) which are capable of differentiating into a number of 
different cell types of mesoderm lineages, including adipocytes, osteocytes, chondrocytes, and 
other mesodermal cells (Fillmore et al. 2005).  They are generally cultured by using colony 
forming unit fibroblasts.  Raw or ficoll-purified bone marrow is placed onto the plates.  
Mesenchymal stem cells can exhibit signs of adherence to the tissue culture plastic within 1-2 
days.  Hematopoietic cells do not adhere.  Also, flow cytometers are used to filter for STRO-1 
markers. Lin and Bo experimented with mature adult progenitor cells to see how well they 
differentiate into hepatocyte like cells.  They used a 21 gauge needle inserted into the bone 
which was then flushed with Dulbecco’s modified Eagles medium (DMEM).  The cells were 
then centrifuged with a Ficoll step gradient of 1.077g/ml at 1500 rpm.  Mononuclear cells were 
then collected and re-suspended in Dulbecco’s modified Eagles medium with 10% fetal bovine 
serum (Fillmore et al. 2005). This process was done for both chondrocytes and osteoblasts. For 
chondrocytes, enough extracellular matrix was formed to adequately plug areas of tissue damage 
in knee joints. For osteoblasts, mineral deposits were observed to show that the osteoblasts were 
indeed calcifying the extracellular matrix and creating bone. This has had strong clinical success 
and will hopefully be available as bone replacement in the near future. It is also important to note 
that mature adult progenitor cells are currently the only type of stem cell approved by the FDA 
for medical application. This is mostly due to the fact that as mature adult progenitor cells or 
only multipotent, they do not exhibit the exponential growth of embryonic or cord derived stem 
cells, thus not posing a risk of cancer or teratoma formation. However, the main obstacle of 
mature adult progenitor cells are they are very limited in clinical applications due to their very 
stable properties. It has been speculated that with dedifferentiation, this obstacle might be 
overcome. Through several unique pathways, namely the NOGGIN pathway, it is possible to 
reprogram an already differentiated adult cell back to its basic non-differentiated state, thus 
having the same capabilities as embryonic stem cells, but not have the rapid mitotic 
characteristic that can become cancerous. (Cai et al. 2007). Dedifferentiation is not a farfetched 
concept as it is seen in many amphibians, animals and even humans. Amphibians, have exhibited 
the ability to regenerate damaged organs to fully functional states (Davenport 2005). This makes 
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a strong argument for dedifferentiation to be funded and researched extensively, as it might hold 
the key for repairing damaged organs in humans as well. 
CORD-DERIVED MESENCHYMAL STEM CELLS 
Data supports the indication that cord derived mesenchymal stem cells are a unique 
combination of the positive qualities of both adult progenitor and human embryonic stem cells, 
with none of the disadvantages either of those cells exhibit. They are extremely proliferative due 
to its embryonic nature (not quite as proliferative as human embryonic stem cells), yet have 
developed enough to exhibit signs of mature progenitor cells. This allows them to be 
programmed to differentiate into specific types of cells. Additionally, due to their chronological 
proximity to their phenotypic state, it is quite possible that certain cells are original stem cells 
much like those found in the human embryo. Drawbacks include possible rejection by host 
because they already have markers. Much like the idea of a human leukocyte antigen bank for 
human embryonic stem cells, the same concept would benefit mesenchymal cells, allowing for 
quick and accurate matches specific to the host. Due to the combined benefits of cord-derived 
cells, it would seem that extensive funding and research would yield many advances and 
discoveries in gene therapy as well as the field of regenerative medicine. It is also important to 
note that the nature in which these cells are derived pose no ethical quandaries, as these stem 
cells are derived from discarded placenta. Additionally, they are relatively easy to isolate and can 
be utilized in the lab at minimal cost. 
2. SCAFFOLDING 
While cells may proliferate and grow, they need to be guided and assembled in a proper 
dimensional order. This can only be achieved with the proper scaffold to direct it. Primarily, to 
meet the specific needs of the cell, the scaffold must be porous, adhesive, biodegradable, and 
include a mechanism for nutrient supply. 
Porosity insures that nutrients can get to the cell and waste can be removed. Adhesion 
will allow for the cells to adhere to the scaffold so that it may grow in the direction desired. 
Additionally, in vivo, this prevents encapsulation of implanted tissue, thus allowing nutrients and 
wastes to be exchanged.  Biodegradability will insure that the scaffold will disappear so that 
remnants do not become toxic and mechanical functions perform properly. Finally, the scaffold 
should be made of materials that function to supply nutrients to growing cell so that all cells that 
adhere are being fed. 
It is crucial to note, however, that simply seeding the cells on a scaffold will not suffice. 
Cells operate and communicate with each other from early on, and even though cells may be of 
the same lineage, they have adapted different roles in any given system. For example, 
hepatocytes have different functions based on their location in relation to their oxygen gradient. 
Some tasked with being glycolytic hepatocytes can be transformed into gluconeogenic 
hepatocytes. Therefore, in a lab environment where oxygen perfusion is at a 100% 
homogeneously, it would result in cells not functioning to their specific characteristics (Lenas et 
al. 2008). A thorough understanding and study of cell mimetics is important in order for 
scaffolding to be effective. 
BIOLOGICAL SCAFFOLDING 
Through the process of decellularization, cells are stripped of the extra cellular matrix 
leaving behind just fibers and collagen. When applied to fully formed tissue or complete organs, 
the only left behind is a translucent, or ghost, extracellular matrix. This is ideal, as within the 
extracellular matrix all the intricate vascular and collecting networks are left in place. This 
allows for the reseeding of those areas to be more specific and accurate. Additionally, this 
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process serves to leave all mechanical functions working properly, and retains all the natural 
mechanics of the organ. In fact, in a study published by Nature Medicine, after eight days of 
reseeding a decellularized rat heart, it was able to conduct complete electrical myocardial 








The cells are stripped of the extracellular matrix through the utilization of detergents – 
most commonly sodium dodecyl sulphate. However, it has been discovered that sodium dodecyl 
sulphate may destroy up to 80 % of the collagen found in the matrix (Petersen et al. 2012). To 
counteract the chemical destruction of part of the extracellular matrix, TritonX-100/sodium-
Figure 1: Photographs of cadaveric perfusion decellularization of whole rat hearts perfused 
with sodium dodecyl sulphate (SDS) over 12 h. (a) The heart becomes more translucent as 
cellular material is washed out from the right ventricle, then the atria and finally the left 
ventricle. (b) Haematoxylin–eosin staining of thin sections of SDS-treated heart showing no 
intact cells or nuclei. Maintenance of large vasculature conduits (asterisks). Scale bar, 200 
µm. (c) Formation of a working perfused bioartificial heart-like construct by 
recellularization of decellularized cardiac extracellular matrix. Recellularized whole rat 
heart at day 4 of perfusion culture in a working heart bioreactor. (d) Representative 
functional assessment tracing of decellularized whole heart construct paced in a working 
heart bioreactor. Tracings of electrocardiogram (ECG), aortic pressure (afterload) and left 
ventricular pressure (LVP) of the paced construct on day 8 after recellularization, and on 
day 8 after stimulation with physiological (B50–100 mM) doses of phenylephrine.  Source: 
Ott et al. 2008 
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deoxycholate was added. In a study done by Drexel University, researchers were able to combine 
sodium-deoxycholate with sodium dodecyl sulphate to achieve minimal to no extracellular 
matrix loss (Fitzpatrick et al. 2010). Additionally it was discovered through the use of 
electroporation, cells were able to be lysed without damage to the extracellular matrix. 
Electroporation is defined as a “non-linear biophysical process in which the application of pulsed 
electric fields lead to an increase in permeability of cells, presumably through the creation of 
nanoscale pores in the lipid bi-layer. At low pulsing energy, this permeability is reversible and 
cellular health and function is maintained. Once a critical electric field intensity threshold is 
surpassed (approximately 500 to 700 V/cm for ninety 50 μs pulses at 4 Hz in the brain and eight 
100 μs pulses at 1 Hz in the liver, respectively),the cell membrane is unable to recover and cell 
death is induced in a precise and controllable manner with sub-millimeter resolution” (Sano et al. 
2010). This process is referred to as non-thermal irreversible electroporation (N-TIRE). Clinical 
successes include the first woman to receive a tracheal transplantation seeded with her somatic 
mature adult progenitor stem cells in 2011. 
However, the main drawback to biological scaffolding is the limited supply of donor 
organs to strip cells of. Even more importantly, specific dimensions needed for implantation is 
not possible with already formed biological scaffolding. In the case of a damaged right ear that 
needs to be matched with the remaining left one, exact dimensions and proportions are required. 
Clearly this would not be possible with scaffolding that is already shaped. It should be noted 
though that decellularization has had the most success with tissues that do not require specific 
dimensions, like a trachea. 
SYNTHETIC SCAFFOLDING 
Synthetic scaffolds can be comprised of either biological (natural) polymers such as 
chitosan, collagen, and polycaprolactone (PCL), or synthetic polymers such as poly(α-
hydroxyacid) and polyglycolic acid (PGA).  Most utilize some form of polylactic acid (PLA) and 
their copolymers (PLGA). There are a variety of techniques that have been utilized and reviewed 
for processing three-dimensional porous scaffolds. (Ikada 2006). Although it has been shown 
that synthetic polymers have advantages over natural polymers, such as straightforward control 
of bioabsorption rate and tunable mechanical properties, their surfaces are hydrophobic, thus 
preventing cell and tissue adhesion and requiring proper treatment to insure that these synthetic 
scaffolds absorb culture medium (Tamada et al. 1986). Additionally, the rate of degradation can 
be controlled and timed to coincide with cell to cell adherence when scaffolding support is no 
longer necessary (Jovanovic et al.). This process of hydrolytic degradation can be obtained via 
two methods. One is done by bulk degradation, and the second method used is through the 
process of surface erosion.  “Bulk degradation can be observed if during random chain scission, 
an overall decrease of molar mass is exhibited. Surface erosion, is the process where hydrolysis 
removes only polymeric chains from the outer layer of the material thus leaving the bulk of the 
material untouched” (Yang et al. 2007). Surface erosion is favored for many applications of 
polymeric biomaterials due to the material properties remaining virtually intact, as degradation 
proceeds through removal of very thin layers of the material. This insures that the scaffold is no 
longer present to hinder any possible affects on mechanical function or toxic interference with 
cell communication. Most importantly, synthetic scaffolding offers the obvious advantage of 
precise and custom dimensional properties. This precision clearly is a need for partial tissue or 
organ repair that requires specific sections to be replicated. Additionally, exact proportions might 
be utilized for aesthetic reasons as well, such as seeding a scaffold with cartilaginous tissue in 
order to build one ear so that it complements the other ear. Furthermore, availability is a non 
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issue as supply is not dependant on any other factors other than procurement of the materials 
needed. The biggest obstacle that needs to be overcome is functionality. The scaffold designed 
must meet all the requirements outlined in order to allow the cells to proliferate and migrate in 
the proper direction. Of the many scaffolding that has been experimented with, only a select few 
have had much success in the clinical phase. With many materials to experiment with, the 
process is mostly done by trial and error with eventual successful results. It is with this fact that 
it seems the next big breakthrough is bound to happen relatively soon.  
CONCLUSION 
There is no doubt that the science of biomedical engineering still has much to accomplish 
in making the technology a widely accessible application in the clinical setting. Though cord, or 
placental, stem cells seem to offer the most promise for continued groundbreaking in the 
regenerative field because they lack many of the obstacles faced by embryonic and adult stem 
cells, currently, the use of mature adult progenitor cells is the only one approved by the FDA for 
cell therapy. A beneficial step forward for stem cells would be to create a human leukocyte 
antigen bank that has all cell type/markers available so that regenerative growth can be done 
quickly with no need for immuno-suppressive drugs due to human leukocyte antigen matching. 
Cells, when combined with synthetic polymer scaffolding, can proliferate and take up their three-
dimensional shape freely. Indeed, the proper treatments of the scaffold must be maintained, and 
biodegradation via lysozymal activities and pathways must be closely monitored to insure proper 
profusion with minimal toxicity. With clinical trials currently underway, the near eventuality of 
full organ replication looks promising. 
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